CEDBCAM aims is to become a globally relevant and leading African company   contributing to unraveling the mysteries into the transmission dynamics, epidemiology   and pathogenomics of antimicrobial resistance (AMR) and related infectious diseases   across the animal, human and environmental interface. We also seek to provide innovative ways of improving prevention, diagnosis and treatment of AMR using state-of-the-art technologies.

CEDBCAM encourages proper use of antibiotics by the population, by monitoring contamination of antibiotic residuals, antibiotic resistance genes, and antibiotic resistant bacteria in food products, drinking and waste water, as well as in the environment (public and household toilets/latrines). CEDBCAM is supporting projects and activities that are investigating the consequences of inadequate water, sanitation and hygiene (WASH) provisions on AMR in community and its environmental compartments, in order to provide further insight and evidence into the burden and transmission routes and dynamics of AMR in low-and-middle-income countries. We are committed to safeguard efficacy of antibiotics for future generations in order to contribute to the achievement of sustainable development goals.

To achieve its goals, CEDBCAM conducts multidisciplinary research activities in four main Scientific Programs in line with the “One Health” approach namely:

  • Epidemiology and Prevention of AMR and Infectious Diseases,
  • Food Safety and Security,
  • Environmental Health,
  • Reproductive, Maternal, Newborn and child Health.

A fifth area of research is the development of diagnostic tools and design of alternative treatments of resistant infectious diseases, mainly in collaboration with partners.